Here, we show using in‐house and publicly‐available datasets, Idh1‐mutant mouse models, and CRISPR‐edited cell lines that somatic gain‐of‐function IDH mutations are associated, plausibly causally, with DNA hypermethylation and CIMP in CRC. This evidence concerns the gene IDH2 and colorectal carcinoma.